Ibuprofeno Winadol

Ibuprofen, the active ingredient in Ibuprofeno Winadol, is a nonsteroidal anti‑inflammatory drug (NSAID) presented as an oral dosage form for oral use. It treats pain, fever and inflammation in adults and children as appropriate.

GNH USA supplies Ibuprofeno Winadol as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Ibuprofeno Winadol is an NSAID that alleviates symptoms across several common painful and inflammatory conditions.

- Mild to moderate pain: provides analgesic relief for headaches, dental pain, musculoskeletal aches, and menstrual cramps. - Fever: reduces elevated body temperature associated with viral or bacterial infections. - Inflammatory conditions (e.g., osteoarthritis, rheumatoid arthritis): decreases swelling, improves joint mobility, and lessens discomfort.

Adverse reactions may range from mild to severe and should be monitored during therapy.

Common Side Effects: - Gastrointestinal discomfort: nausea, dyspepsia, or abdominal pain. - Headache: transient mild to moderate headache. - Dizziness: occasional light‑headedness. - Skin rash: mild erythema or itching.

Serious or Rare Side Effects: - Gastrointestinal bleeding or ulceration. - Acute renal impairment or failure. - Severe hypersensitivity reactions, including anaphylaxis or Stevens‑Johnson syndrome.

Before initiating therapy, consider the following safety measures.

- Assess renal function: adjust or avoid use in patients with significant kidney disease. - Monitor gastrointestinal health: contraindicated in active peptic ulcer disease or severe gastritis. - Avoid concomitant anticoagulants: increased risk of bleeding when combined with warfarin or similar agents. - Use with caution in asthma: may precipitate bronchospasm in susceptible individuals. - Store at ambient temperature: keep in the original container, protect from moisture and direct sunlight.

Ibuprofeno Winadol can interact with several medication classes; awareness helps prevent adverse outcomes.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): heightened risk of serious bleeding. - Selective serotonin reuptake inhibitors (SSRIs): additive hemorrhagic potential. - Other NSAIDs or COX‑2 inhibitors: cumulative gastrointestinal toxicity.

Moderate Interactions (Monitor Closely): - ACE inhibitors (e.g., enalapril): may reduce renal perfusion and function. - Diuretics (e.g., furosemide): increased risk of renal impairment. - Lithium: ibuprofen can raise serum lithium concentrations, requiring monitoring.